Development of Engineered T Cells Expressing a Chimeric CD16-CD3ζ Receptor to Improve the Clinical Efficacy of Mogamulizumab Therapy Against Adult T-Cell Leukemia
| Image |  |
|---|---|
| Description | scientific article published on 18 April 2016 |
| Author/s |
author: Hiroshi Shiku Takashi Sugiyama |
| Publication date | April 18, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |